Press Release

Corcym Announces Growth Financing To Accelerate International Expansion and Strategic Growth Initiatives

(London) December 23, 2021 - Corcym (UK) Holding (“The Company” or “Corcym”) today announced it has closed a €45 million growth financing with funds managed by Hayfin Capital Management LLP (“Hayfin”). The investment, structured as a combination of preferred equity and a senior credit facility, will be used to accelerate Corcym’s international expansion, strategic growth initiatives and business development.
The obligations under the Credit Facility will be guaranteed on a senior-secured basis by Corcym and each of Corcym’s existing and future wholly owned material subsidiaries, and such investment will be secured by a perfected first priority security interest in substantially all tangible and intangible assets of Corcym, subject in each case to certain exceptions contained in the Credit Facility.
“We are pleased to bring in Hayfin, a leading healthcare investor in both Europe and North America, as part of our capital structure,” said Christian Mazzi, Chief Executive Officer of Corcym. “This transaction allows Corcym to accelerate the execution of its strategy and growth plan.”
Howard Rowe, Managing Director and Head of Healthcare at Hayfin, stated: "Hayfin looks to back innovative, high-growth healthcare businesses and our investment in Corcym, with its leadership position in its key markets and global expansion plans, is consistent with this strategy. We look forward to supporting Corcym’s management team to help it achieve the Company's strategic growth objectives and capitalize on the opportunities for Corcym to expand its competitive position in the structural heart industry."
“We are delighted to be partnering with Hayfin, once again, and look forward to building together the leading company focused on cardiac surgeons and their patients,” said Robert Watson, Partner at Gyrus Capital.

For media information:

CORCYM Corporate Communication

communication@corcym.com